CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Alzheimer's disease (AD) is the most common form of dementia. In the brains of people with AD, certain small substances stick toget ...
Phase 2
Berlin, Germany and 37 other locations
This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in p...
Phase 2
Berlin, Germany and 62 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...
Phase 3
Berlin, Germany and 105 other locations
administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's...
Phase 2
Berlin, Germany and 73 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...
Phase 3
Berlin, Germany and 247 other locations
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...
Phase 3
Steglitz, Germany and 141 other locations
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...
Phase 3
Berlin, Germany and 290 other locations
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...
Phase 3
Berlin, Germany and 149 other locations
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...
Phase 3
Berlin, Germany and 200 other locations
This clinical trial is recruiting people who either are at risk of AD - have build-up of beta-amyloid, but have no clinical symptoms, or with a diagn...
Phase 2
Berlin, Germany and 47 other locations
Clinical trials
Research sites
Resources
Legal